Welcome to the Digital Pathology & AI in GI & Fibrotic Diseases Summit
Standardizing Biomarkers & Endpoints with ML & AI
AI-based image analysis is transforming understanding of therapeutic efficacy, disease progression, and patient enrolment. Historically reserved for diagnostic analysis of oncology, evolving applications of digital pathology in NASH, IBS, IBD, CKD, Crohn’s Disease, CVD and more has catalysed new approaches to de-risking clinical development through more standardized and cost-effective tissue analysis.
With a sharp focus on leveraging digital pathology and ML beyond oncology, the
Digital Pathology & AI in GI & Fibrotic Diseases Summit is committed to bringing together industry leaders to enhance imaging technologies and algorithm development, evaluate histology as a primary endpoint in trials, and help clarify disease pathology to execute precision medicine.
Testimonials from the Hanson Wade CVRM Series:
“Powerful, key players in one room to move the field forward” Vertex Pharmaceuticals
“High quality opportunity to be exposed to hot topics in kidney disease research in Pharma and Biotech” Janssen
“Great topics, great presenters, excellent renal science” Novo Nordisk
Other Events in the Series
